Acute myocardial infarction after subcutaneous administration of sumatriptan

Authors

  • Luis A. Rodríguez López Hospital Universitario Celestino Hernández Robau. Santa Clara, Villa Clara, Cuba.
  • Eliany Rodríguez Moreno Universidad de Ciencias Médicas Dr. Serafín Ruiz de Zárate Ruiz. Santa Clara, Villa Clara, Cuba.
  • Reinaldo Gavilánez Hernández Hospital Universitario Celestino Hernández Robau. Santa Clara, Villa Clara, Cuba.
  • Yorsenka Milord Fernández Hospital Universitario Celestino Hernández Robau. Santa Clara, Villa Clara, Cuba.
  • José M. Ercia Arenal Hospital Universitario Celestino Hernández Robau. Santa Clara, Villa Clara, Cuba.
  • Alexánder Triana Díaz Hospital Universitario Celestino Hernández Robau. Santa Clara, Villa Clara, Cuba.
  • Ángel Cuéllar Gallardo Hospital Universitario Celestino Hernández Robau. Santa Clara, Villa Clara, Cuba.

Abstract

Sumatriptan is a drug used for migraine which can produce coronary vasoconstriction. The case of a 50-year-old male with no history of cardiovascular disease who suffered an acute myocardial infarction, of non-atherosclerotic cause, as a result of the subcutaneous administration of this drug is reported. The patient did not show complications after drug withdrawal.

Downloads

Download data is not yet available.

Downloads

Published

2015-10-11

How to Cite

1.
Rodríguez López LA, Rodríguez Moreno E, Gavilánez Hernández R, Milord Fernández Y, Ercia Arenal JM, Triana Díaz A, et al. Acute myocardial infarction after subcutaneous administration of sumatriptan. CorSalud [Internet]. 2015 Oct. 11 [cited 2025 Jun. 27];7(4):322-5. Available from: https://revcorsalud.sld.cu/index.php/cors/article/view/81

Issue

Vol. 7 No. 4 (2015)

Section

CASE REPORTS

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.